Decentralized Clinical Trial Oversight: The COVID-19 Effect

Improve Decentralized Trial Execution and Operational Efficiencies with RBQM The COVID-19 pandemic has placed greater importance on risk management, and has required clinical trial sites, sponsors, and clinical research organizations (CROs) to adopt remote and risk-based quality management (RBQM) methodologies for clinical trial execution to: Many have recognized great improvements in trial execution and operational efficiencies with this adoption, while others are struggling with how to implement an RBQM approach. Read this white paper to learn the current state of RBQM approaches to providing decentralized clinical oversight, and the value that adopting these approaches brings to sponsors, CROs, sites, and ultimately patients.